Empower Signs Exclusive Content Deal To Further Convert Its’ Database Of 165,000 Patients

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would  kill for.  Add in the fact patient visits increased 351% in Q4 and it  becomes the kind of company small cap investors have been dying to find  as they watch pretender companies melt away.

But it doesn’t end there.

CBD extraction has been a key element of the company’s vertical  integration. Producing its’ own hemp-derived CBD products for its own  massive patient list just makes sense. However, thanks to an LOI (moving  towards definitive agreement) to JV with extraction experts Heritage  Cannabis, the Company’s 5,000 sq ft facility in Oregon is also planning  to serve big brand 3rd party partners in the USA .  Empower brings the  infrastructure, Heritage brings the expertise and balance sheet.  The  result is a match made in shareholder heaven with initial annual  capacity of 6,000 Kg at ~ $US 5,000 per Kg, which adds up to $US  30,000,000 in potential revenue.

But It Doesn’t End There

The Company’s CEO, Steven McAuley is Six Sigma certified under the  quality initiative of legendary GE chairman Jack Welch. We’ve never seen  a Six Sigma certified CEO in the Canadian small cap markets. Never ….  which also explains how McAuley has brought Empower so far in just 11  months.

If anyone understands digital, it’s McAuley. So it should come as no  surprise the Company just signed an exclusive multi-year, multi-national  licensing deal with EuroLife to license its “Cannvas.me” cloud based  online education platform for the US and Mexico.  Amongst other things,  Empower plans to integrate the education platform into its clinics  across the United States to help further convert their 165,000 patient  database to CBD and medical cannabis through proper education.

The site also contains premium content for physicians who need to  educate themselves and comes with millions of page views already, as  well as, 15,000 opted in subscribers, which explains the $460,000 in  licensing over 3 years – but $210,000 of that is Empower stock priced at  $0.10 (125% above current market prices, which gives you an idea of the  confidence EuroLife principals have in the future of Empower.

P.S.  The interview takes place from the floor of the Arizona  Cannabis Expo, where Empower has multiple booths and an actual pop-up  clinic to acquire new customers in real-time.  That’s what happens when  you have a company run by a Six Sigma Certified CEO.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.